Russia approves Sputnik V COVID-19 vaccine for people over 60 – media

A nurse prepares Russia's "Sputnik-V" vaccine against the coronavirus disease (COVID-19) for inoculation in a post-registration trials stage at a clinic in Moscow

MOSCOW (Reuters) - Russia on Saturday approved its main COVID-19 vaccine, Sputnik V, for use by people over the age of 60, Russian news agencies cited the health ministry as saying.

People over 60 have thus far been excluded from Russia's national inoculation programme, as the shot was tested on this age group separately.

(Reporting by Polina Ivanova; Editing by William Mallard)